This article is an
orphan, as no other articles
link to it. Please
introduce links to this page from
related articles; try the
Find link tool for suggestions. (June 2024) |
![]() | |
Identifiers | |
---|---|
3D model (
JSmol)
|
|
| |
| |
Properties | |
C7H7FN6O2 | |
Molar mass | 226.171 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
KL-50 is a drug candidate designed to treat glioblastoma. It functions by alkylating DNA yielding O6-(2-fluoroethyl)guanine which causes DNA interstrand crosslinks. Half of the cancers are unable to repair the DNA damage. [1] [2] [3] [4]
This article is an
orphan, as no other articles
link to it. Please
introduce links to this page from
related articles; try the
Find link tool for suggestions. (June 2024) |
![]() | |
Identifiers | |
---|---|
3D model (
JSmol)
|
|
| |
| |
Properties | |
C7H7FN6O2 | |
Molar mass | 226.171 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
KL-50 is a drug candidate designed to treat glioblastoma. It functions by alkylating DNA yielding O6-(2-fluoroethyl)guanine which causes DNA interstrand crosslinks. Half of the cancers are unable to repair the DNA damage. [1] [2] [3] [4]